P63 expression in merkel cell carcinoma predicts poorer survival yet may have limited clinical utility

American Journal of Clinical Pathology

Volumn 140, Issue 6, 2013, Pages 838-844

  Stetsenko, Galina Y ^a   Malekirad, Jacqueline ^a   Paulson, Kelly G ^a   Iyer, Jayasri G ^a   Thibodeau, Renee M ^a   Nagase, Kotaro ^a,b   Schmidt, Miranda ^a   Storer, Barry E ^a,c   Argenyi, Zsolt B ^a   Nghiem Dr , Paul ^a,c,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SAGA UNIVERSITY   (Japan)

^c USA   (United States)

^d SEATTLE CANCER CARE ALLIANCE   (United States)

Author keywords

Merkel cell carcinoma; P63; Prognosis; Survival

Indexed keywords

PROTEIN P63;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM;

MERKEL CELL CARCINOMA; P63; PROGNOSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84888236508     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPE4PK6CTBNQJY     Document Type: Article

References (20)

1. Van Keymeulen A, Mascre G, Youseff KK, et al. Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol. 2009;187:91-100
2. Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first onsensus staging system. J Am Acad Dermatol. 2010;63:751-761
3. Crum CP, Mckeon FD. p63 in epithelial survival, germ cell surveillance, and neoplasia. Annu Rev Pathol. 2010;5:349-371
4. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8:494-501
5. Lo Muzio L, Santarelli A, Caltabiano R, et al. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol. 2005;36:187-194
6. Hu H, Xia SH, Li AD, et al. Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer. 2002;102:580-583
7. Fukushima N, Satoh T, Sueoka N, et al. Clinico-pathological characteristics of p63 expression in B-cell lymphoma. Cancer Sci. 2006;97:1050-1055
8. Moergel M, Abt E, Stockinger M, et al. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma. Oral Oncol. 2010;46:667-671
9. Hanker L, Karn T, Ruckhaeberle E, et al. Clinical relevance of the putative stem cell marker p63 in breast cancer. Breast Cancer Res Treat. 2010;122:765-775
10. Leite KR, Srougi M, Sanudo A, et al. The use of immunohistochemistry for diagnosis of prostate cancer. Int Braz J Urol. 2010;36:583-590
11. de Biase D, Morandi L, Degli Esposti R, et al. p63 short isoforms are found in invasive carcinomas only and not in benign breast conditions. Virchows Arch. 2010;456:395-401
12. Asioli S, Righi A, Volante M, et al. p63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer. 2007;110:640-647
13. Asioli S, Righi A, de Biase D, et al. Expression of p63 is the sole independent marker of aggressiveness in localised (stage 1-2) Merkel cell carcinomas. Mod Pathol 2011;24:1451-1461
14. Hall BJ, Pincus LB, Yu SS, et al. Immunohistochemical prognostication of Merkel cell carcinoma: p63 expression but not polyomavirus status correlates with outcome. J Cutan Pathol. 2012;39:911-917
15. Kim J, McNiff JM. Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma. Mod Pathol. 2008;21:764-769
16. Lim CS, Whalley D, Haydu LE, et al. Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma. Ann Surg Oncol. 2012;19:3325-3334
17. Burford HN, Adams AL, Hameed O. Effect of storage on p63 immunohistochemistry: a time-course study. Appl Immunohistochem Mol Morphol. 2009;17:68-71
18. McCarthy K, Miller L, Cox E, et al. Estrogen receptor analysis: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109:716-721
19. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124
20. Albores-Saavedra J, Batich K, Chable-Montero F, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010;37:20-27